Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising cytotoxic agent discovered at Taxolog

April 5, 2004

Potent, selective VEGFR tyrosine kinase inhibitor presented by Pfizer at AACR meeting

April 5, 2004

Synergistic effects of Targretin and cytotoxic agents in breast cancer and NSCLC

April 5, 2004

Systemic radioprotective effects found for CG-53135 in irradiated mice

April 5, 2004

Preclinical data on the antitumor efficacy and hematological safety of C-1311

April 5, 2004

A VEGF-gelonin fusion protein inhibits metastasis to lung in a breast cancer model

April 5, 2004

Dosing commences in phase IIa trial of BCX-1777

April 5, 2004

Oral recombinant human lactoferrin inhibits tumor growth

April 5, 2004

Pfizer presents data on PD-0325901, a more potent and pharmaceutically improved analogue of CI-1040

April 2, 2004

Ki-23057, a potent, metabolically stable inhibitor of FGFR2 characterized by Kirin

April 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026